Oral Ultramicronized-Palmitoylethanolamide (um-PEA; 600 mg per day) in tablet form: clinical trials recruiting now
Fewer than 3 recruiting trials found.
1
Recruiting trials
8
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Not applicable 1
Conditions being studied
| Condition | Trials |
|---|---|
| Anxiety | 1 |
| Anxiety State | 1 |
| Asperger Syndrome | 1 |
| Autism | 1 |
| Autism Spectrum Disorder | 1 |
| Autism Spectrum Disorder High-Functioning | 1 |
| Depression | 1 |
| Depressive Symptoms | 1 |
Recruiting trials involving Oral Ultramicronized-Palmitoylethanolamide (um-PEA; 600 mg per day) in tablet form
Common questions
How many recruiting trials involve Oral Ultramicronized-Palmitoylethanolamide (um-PEA; 600 mg per day) in tablet form?
1 recruiting trial across 8 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.